Perspectives: FDA warns umbilical firm & continues stream of “mini-warning” letters
Yesterday we learned that the FDA issued a warning letter to the cord stem cell firm, Cord for Life. In this warning, the FDA indicated that the firm’s product is actually a drug product and lacks necessary pre-market approvals. In addition, the agency highlighted apparent deviations from CGMP practices. The most important part of the […]
Perspectives: FDA warns umbilical firm & continues stream of “mini-warning” letters Read More »